Skip to main content
Log in

Prolonged Tpeak–Tend interval in anti-Ro52 antibody-positive connective tissue diseases

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Patients with connective tissue diseases (CTDs) may have prolonged corrected QT interval which indicates increased risk for ventricular arrhythmias. However, a more sensitive measure of ventricular repolarization, T-peak-to-end (Tpe) interval, has not been studied in CTDs. We aimed to investigate the relationship between ventricular repolarization abnormalities and anti-Ro52-positivity in subjects with connective tissue diseases (CTDs). We enrolled patients with anti-Ro52-positive CTDs, ANA-positive CTDs, and healthy subjects in this cross-sectional study. We excluded conditions potentially affecting the QT interval. We compared the ECG measures between the groups and performed analyses to define factors associated with ventricular repolarization measures. 15 ANA and anti-Ro52-positive, 39 ANA-positive and anti-Ro52-negative, and 22 healthy subjects were enrolled. None of the subjects had rhythm or conduction disturbances. Corrected QT intervals were similar between the groups. Tpe (84, 77.3, and 69.4 msn, respectively) and QT-dispersion (40, 27.2, and 20.1 msn, respectively) were higher in anti-Ro52-positive subjects compared with the ANA-positive and healthy subjects. Anti-Ro52 titers were correlated with Tpe and QT-dispersion (r = 0.52 and p < 0.001 for each). ANA and anti-Ro52-positivity were independently associated with higher Tpe (OR = 7.7, p = 0.001 and OR = 6.9, p = 0.001, respectively), corrected Tpe (OR = 11.3, p = 0.001 and OR = 8.4, p = 0.003, respectively), QT dispersion (OR = 7, p = 0.008 and OR = 13, p < 0.001, respectively), and QTc dispersion (OR = 9.1, p = 0.001 and OR = 14.1, p < 0.001, respectively). This study provides evidence that ANA positivity, especially when concomitant anti-Ro52-positivity is present, significantly deteriorates ventricular repolarization. The aforementioned ventricular repolarization abnormalities may render these subjects susceptible to serious rhythm or conduction disorders in the setting of predisposing conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lazzerini PE, Capecchi PL, Laghi-Pasini F (2010) Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses. Scand J Immunol 72(3):213–222. doi:10.1111/j.1365-3083.2010.02428.x

    Article  CAS  PubMed  Google Scholar 

  2. Ambrosi A, Sonesson SE, Wahren-Herlenius M (2014) Molecular mechanisms of congenital heart block. Exp Cell Res 325(1):2–9. doi:10.1016/j.yexcr.2014.01.003

    Article  CAS  PubMed  Google Scholar 

  3. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL (2000) QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 43(5):1049–1053. doi:10.1002/1529-0131(200005)43:5<1049:aid-anr13>3.0.co;2-x

    Article  CAS  PubMed  Google Scholar 

  4. Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F (2004) Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 50(4):1248–1252. doi:10.1002/art.20130

    Article  PubMed  Google Scholar 

  5. Lazzerini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, Costa A, Maggio R, Garcia-Gonzalez E, Bisogno S, Morozzi G, Galeazzi M, Laghi-Pasini F (2007) Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 100(6):1029–1034. doi:10.1016/j.amjcard.2007.04.048

    Article  PubMed  Google Scholar 

  6. Lazzerini PE, Capecchi PL, Acampa M, Morozzi G, Bellisai F, Bacarelli MR, Dragoni S, Fineschi I, Simpatico A, Galeazzi M, Laghi-Pasini F (2011) Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity. Arthritis Care Res (Hoboken) 63(10):1463–1470. doi:10.1002/acr.20540

    Article  CAS  Google Scholar 

  7. Lazzerini PE, Department of Medical Sciences SaN, University of Siena, Italy, lazzerini7@unisi.it, Capecchi PL, Department of Medical Sciences SaN, University of Siena, Italy, Laghi-Pasini F, Department of Medical Sciences SaN, University of Siena, Italy (2015) Long QT syndrome: an emerging role for inflammation and immunity. Front Cardiovasc Med. doi:10.3389/fcvm.2015.00026

    Google Scholar 

  8. Lazzerini PE, Capecchi PL, Laghi-Pasini F (2015) Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications. Heart Rhythm 12(2):449–454. doi:10.1016/j.hrthm.2014.10.031

    Article  PubMed  Google Scholar 

  9. Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, Fortin PR, Merrill JT, Romero-Diaz J, Sanchez-Guerrero J, Fessler B, Alarcón GS, Steinsson K, Bruce IN, Ginzler E, Dooley MA, Nived O, Sturfelt G, Kalunian K, Ramos-Casals M, Petri M, Zoma A, Pineau CA (2015) Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care Res (Hoboken) 67(1):128–135. doi:10.1002/acr.22370

    Article  Google Scholar 

  10. Massie C, Hudson M, Tatibouet S, Steele R, Huynh T, Fritzler MJ, Baron M, Pineau CA, CSRG (2014) Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients. Semin Arthritis Rheum 44(3):338–344. doi:10.1016/j.semarthrit.2014.07.001

    Article  CAS  PubMed  Google Scholar 

  11. Nomura A, Kishimoto M, Takahashi O, Deshpande GA, Yamaguchi K, Okada M (2014) Prolongation of heart rate-corrected QT interval is a predictor of cardiac autonomic dysfunction in patients with systemic lupus erythematosus. Rheumatol Int 34(5):643–647. doi:10.1007/s00296-013-2718-z

    Article  CAS  PubMed  Google Scholar 

  12. Antzelevitch C (2001) T peak-Tend interval as an index of transmural dispersion of repolarization. Eur J Clin Invest 31(7):555–557

    Article  CAS  PubMed  Google Scholar 

  13. Goldner B, Brandspiegel HZ, Horwitz L, Jadonath R, Cohen TJ (1995) Utility of QT dispersion combined with the signal-averaged electrocardiogram in detecting patients susceptible to ventricular tachyarrhythmia. Am J Cardiol 76(16):1192–1194

    Article  CAS  PubMed  Google Scholar 

  14. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC (2006) Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47(2):362–367. doi:10.1016/j.jacc.2005.08.067

    Article  PubMed  Google Scholar 

  15. Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, Gunson K, Jui J, Chugh SS (2011) Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol 4(4):441–447. doi:10.1161/circep.110.960658

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z, Qu Y, El-Sherif N, Zhou Z, January C, Hussain MM, Jiang XC, Sobie EA, Wahren-Herlenius M, Chahine M, Capecchi PL, Laghi-Pasini F, Lazzerini PE, Boutjdir M (2015) Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation 132(4):230–240. doi:10.1161/circulationaha.115.009800

    Article  CAS  PubMed  Google Scholar 

  17. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22(7):1259–1264

    CAS  PubMed  Google Scholar 

  18. Buyon JP, Clancy RM, Friedman DM (2009) Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Int Med 265(6):653–662. doi:10.1111/j.1365-2796.2009.02100.x

    Article  CAS  Google Scholar 

  19. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52(2):402–411. doi:10.1002/art.20853

    Article  PubMed  Google Scholar 

  20. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13(9):936–944. doi:10.1016/j.autrev.2014.05.007

    Article  PubMed  Google Scholar 

  21. Costedoat-Chalumeau N, Amoura Z, Hulot JS, Ghillani P, Lechat P, Funck-Brentano C, Piette JC (2005) Corrected QT interval in anti-SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al. Arthritis Rheum 52(2):676–677. doi:10.1002/art.20845

    Article  PubMed  Google Scholar 

  22. Cardoso CR, Sales MA, Papi JA, Salles GF (2005) QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 14(10):846–852

    Article  CAS  PubMed  Google Scholar 

  23. Milovanovic B, Stojanovic L, Milicevik N, Vasic K, Bjelakovic B, Krotin M (2010) Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk. Srp Arh Celok Lek 138(1–2):26–32

    Article  PubMed  Google Scholar 

  24. Bourre-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P, Pineau CA (2011) Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 63(7):1031–1037. doi:10.1002/acr.20470

    Article  Google Scholar 

  25. Teixeira RA, Borba EF, Pedrosa A, Nishioka S, Viana VS, Ramires JA, Kalil-Filho R, Bonfá E, Martinelli Filho M (2014) Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus. Europace 16(6):887–892. doi:10.1093/europace/eut290

    Article  PubMed  Google Scholar 

  26. Sgreccia A, Morelli S, Ferrante L, Perrone C, De Marzio P, De Vincentiis G, Scopinaro F (1998) QT interval and QT dispersion in systemic sclerosis (scleroderma). J Int Med 243(2):127–132

    CAS  Google Scholar 

  27. Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD (2015) Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol 42(3):421–428. doi:10.3899/jrheum.140861

    Article  CAS  PubMed  Google Scholar 

  28. Eickhoff CS, Lawrence CT, Sagartz JE, Bryant LA, Labovitz AJ, Gala SS, Hoft DF (2010) ECG detection of murine chagasic cardiomyopathy. J Parasitol 96(4):758–764. doi:10.1645/ge-2396.1

    Article  PubMed  PubMed Central  Google Scholar 

  29. Saribayev M, Tufan F, Oz F, Erer B, Ozpolat T, Ozturk GB, Akin S, Saka B, Erten N, Tascioglu C, Karan A (2014) Corticosteroid treatment normalizes QTc prolongation and improves heart block in an elderly patient with anti-Ro-positive systemic lupus erythematosus. Aging Clin Exp Res 26(3):337–339. doi:10.1007/s40520-013-0168-9

    Article  PubMed  Google Scholar 

  30. Santos-Pardo I, Martinez-Morillo M, Villuendas R, Bayes-Genis A (2013) Anti-Ro antibodies and reversible atrioventricular block. N Engl J Med 368(24):2335–2337. doi:10.1056/NEJMc1300484

    Article  CAS  PubMed  Google Scholar 

  31. Villuendas R, Olive A, Junca G, Salvador I, Martinez-Morillo M, Santos-Pardo I, Pereferrer D, Zamora E, Bayes-Genis A (2014) Autoimmunity and atrioventricular block of unknown etiology in adults: the role of anti-Ro/SSA antibodies. J Am Coll Cardiol 63(13):1335–1336. doi:10.1016/j.jacc.2013.10.086

    Article  PubMed  Google Scholar 

  32. Santos-Pardo I, Villuendas R, Salvador-Corres I, Martinez-Morillo M, Olive A, Bayes-Genis A (2015) Anti-Ro/SSA antibodies and cardiac rhythm disturbances: present and future perspectives. Int J Cardiol 184:244–250. doi:10.1016/j.ijcard.2014.11.002

    Article  PubMed  Google Scholar 

  33. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41(6):567–574. doi:10.1016/j.jelectrocard.2008.07.016

    Article  PubMed  Google Scholar 

  34. Piccirillo G, Cacciafesta M, Lionetti M, Nocco M, Di Giuseppe V, Moise A, Naso C, Marigliano V (2001) Influence of age, the autonomic nervous system and anxiety on QT-interval variability. Clin Sci (Lond) 101(4):429–438

    Article  CAS  Google Scholar 

  35. Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, Di Diego J, Saffitz J, Thomas GP (1999) The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10(8):1124–1152

    Article  CAS  PubMed  Google Scholar 

  36. Wolk R, Stec S, Kulakowski P (2001) Extrasystolic beats affect transmural electrical dispersion during programmed electrical stimulation. Eur J Clin Invest 31(4):293–301

    Article  CAS  PubMed  Google Scholar 

  37. Rautaharju PM, Zhou SH, Gregg RE, Startt-Selvester RH (2011) Electrocardiographic estimates of action potential durations and transmural repolarization time gradients in healthy subjects and in acute coronary syndrome patients–profound differences by sex and by presence vs absence of diagnostic ST elevation. J Electrocardiol 44(3):309–319. doi:10.1016/j.jelectrocard.2010.11.009

    Article  PubMed  Google Scholar 

  38. Barbhaiya C, Po JR, Hanon S, Schweitzer P (2013) Tpeak–Tend and Tpeak–Tend/QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients. Pacing Clin Electrophysiol 36(1):103–108. doi:10.1111/pace.12031

    Article  PubMed  Google Scholar 

  39. Kilicaslan F, Tokatli A, Ozdag F, Uzun M, Uz O, Isilak Z, Yiginer O, Yalcin M, Guney MS, Cebeci BS (2012) Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol 35(8):966–972. doi:10.1111/j.1540-8159.2012.03439.x

    Article  PubMed  Google Scholar 

  40. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR (2001) Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block. J Rheumatol 28(2):366–369

    CAS  PubMed  Google Scholar 

  41. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC (2004) Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 50(10):3187–3194. doi:10.1002/art.20554

    Article  PubMed  Google Scholar 

  42. Motta M, Rodriguez-Perez C, Tincani A, Lojacono A, Chirico G (2007) Outcome of infants from mothers with anti-SSA/Ro antibodies. J Perinatol 27(5):278–283. doi:10.1038/sj.jp.7211688

    Article  CAS  PubMed  Google Scholar 

  43. Lazzerini PE, Capecchi PL, Boutjdir M, Laghi-Pasini F (2015) Comment on “absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients”. Semin Arthritis Rheum 44(5):e16–e17. doi:10.1016/j.semarthrit.2014.10.002

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ercan Cegilli, MD (Department of Cardiology, Uludag University School of Medicine) for his help in measurement of ECG data.

Funding

We thank Bursa Kidney Foundation for their funding support.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ayse Nur Tufan or Saim Sag.

Ethics declarations

Ethical statement

The ethical committee of Uludag University School of Medicine approved the study, and we carried out the study in accordance with the Declaration of Helsinki and its later amendments.

Informed consent

All of the participants provided informed consent.

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tufan, A.N., Sag, S., Oksuz, M.F. et al. Prolonged Tpeak–Tend interval in anti-Ro52 antibody-positive connective tissue diseases. Rheumatol Int 37, 67–73 (2017). https://doi.org/10.1007/s00296-016-3488-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-016-3488-1

Keywords

Navigation